Clinical Trials Directory

Trials / Completed

CompletedNCT03626519

Effects of Menthol on Dyspnoea in COPD Patients

Effects of Menthol on Dyspnoea Induced by Exercise in COPD Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Groupe Hospitalier du Havre · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Chronic obstructive pulmonary disease (COPD) is characterised by non-reversible bronchial obstruction associated with systemic disorders and comorbid factors. Dyspnoea is a common symptom among patients with Chronic Obstructive pulmonary Disease (COPD). Dyspnea is the primary symptom limiting exercise and daily activities in these patients. It has been reported that breathing cold air could decrease dyspnoea induced by exercise and could improve exercise performance. The aim of this study is to carry out the effect of cooling sensation induced by menthol chewing-gum on dyspnoea and exercise performance among patients with COPD.

Conditions

Interventions

TypeNameDescription
OTHERTest with Mentholpatients will perform a Six-minute walk test according to American Thoracic Society guidelines
OTHERTest with placebopatients will perform a Six-minute walk test according to American Thoracic Society guidelines

Timeline

Start date
2019-09-23
Primary completion
2021-03-12
Completion
2021-03-12
First posted
2018-08-13
Last updated
2021-04-23

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03626519. Inclusion in this directory is not an endorsement.